Skip to main content

Table 1 Proportion of patients with breast conserving surgery who underwent radiotherapy and those who refused radiotherapy diagnosed between 2010 and 2015

From: Radiotherapy refusal in breast cancer with breast-conserving surgery

 

Radiotherapy performed

Radiotherapy refused

P-value

 

No

%

No

%

 

Years at diagnosis

2010

12,247

14.40

261

12.10

 < 0.001

2011

13,254

15.60

283

13.20

2012

13,577

16.00

359

16.70

2013

14,048

16.50

321

14.90

2014

15,284

18.00

391

18.20

2015

16,538

19.50

537

25.00

Age

 ≤ 50

17,165

20.20

211

9.80

 < 0.001

 > 50

67,783

79.80

1941

90.20

Income

 < 65,000

40,684

47.90

1328

61.70

 < 0.001

 ≥ 65,000

44,264

52.10

824

38.30

Marital

Married

52,983

62.40

974

45.30

 < 0.001

Single

12,068

14.20

291

13.50

Divorced

19,897

23.40

887

41.20

Race

White

69,215

81.50

1860

86.40

 < 0.001

Black

7855

9.20

170

7.90

Others

7878

9.30

122

5.70

Grade

Grade I + II

62,435

73.50

1660

77.10

 < 0.001

Grade III + IV

22,513

26.50

492

22.90

Stage

Stage I

54,636

64.30

1479

68.70

 < 0.001

Stage II

27,056

31.90

605

28.10

Stage III

3256

3.80

68

3.20

T stage

T1

63,396

74.60

1611

74.90

 < 0.001

T2

19,922

23.50

491

22.80

T3

1335

1.60

29

1.30

T4

295

0.30

21

1.00

N stage

N0

67,975

80.00

1870

86.90

 < 0.001

N1

14,419

17.00

238

11.10

N2

1893

2.20

29

1.30

N3

661

0.80

15

0.70

ER status

Negative

11,098

13.10

208

9.70

 < 0.001

Positive

73,850

86.90

1944

90.30

PR status

Negative

18,823

22.20

396

18.40

 < 0.001

Positive

66,125

77.80

1756

81.60

HER-2 status

Negative

75,448

88.80

1955

90.80

0.003

Positive

9500

11.20

197

9.20

Subtype

HR + /HER-2 + 

7048

8.30

148

6.90

 < 0.001

HR + /HER-2-

67,543

79.50

1809

84.10

HR-/HER-2 + 

2452

2.90

49

2.30

HR-/HER-2-

7905

9.30

146

6.80

Chemotherapy

No

55,663

65.50

1964

91.30

 < 0.001

Yes

29,285

34.50

188

8.70